iCardio.ai
Back to menu
01
Solution name
Short description of the solution, try to keep this to about two sentences.
02
Solution name
Short description of the solution, try to keep this to about two sentences.
03
Solution name
Short description of the solution, try to keep this to about two sentences.
04
Solution name
Short description of the solution, try to keep this to about two sentences.
05
Solution name
Short description of the solution, try to keep this to about two sentences.
See all our solutions
iCardio.ai Joins the Cedars-Sinai Accelerator
iCardio.ai will be deepening its relationship with world-renowned medical center Cedars-Sinai as the company joins the 10th cohort of the Cedars-Sinai Accelerator.
The Cedars-Sinai Accelerator program will greet its 10th accelerator class, featuring 10 innovative health-tech startup companies from the United States and around the globe.
During the three-month program, participating companies will have the opportunity to network and seek mentorship from more than 300 clinicians, executives and resources across Cedars-Sinai.
Participants will receive personalized guidance, support, and exposure to a vast network of healthcare entrepreneurs, investors and advisers to help navigate the companies’ healthcare solutions to the next level.
“We are excited to welcome the teams from the 10 companies in our next cohort of the accelerator. Each group is bringing technology solutions that have the potential to help us deliver healthcare to our patients in a more efficient and cost-effective manner,” said James Laur, JD, chief executive, Intellectual Property and Health Ventures, and co-founder of Cedars-Sinai Accelerator.
Companies in the accelerator’s 10th class are working on various innovative technology-driven healthcare solutions, including software that detects heart disease early, a program that mines data to improve or predict health outcomes, and monitoring devices that provide real-time feedback remotely to promote telehealth.
Each participating company will receive an investment of $100,000 to bolster its product growth and vision.
At the end of the three-month program, as part of Cedars-Sinai’s Demo Day, entrepreneurs will present their products and share their progress at the HLTH Event 2024 conference in Las Vegas to an audience of potential investors, startups, government and healthcare policymakers, health-tech consumers and journalists.
"Building a successful company in the healthcare industry requires more than just a great idea; it demands an understanding of the complexities of healthcare,” said Nirdesh K. Gupta, PhD, managing partner of Cedars-Sinai Intellectual Property Company. “Each accelerator class brings new opportunities for the Cedars-Sinai community to make a difference. We are excited to continue our mission of transforming healthcare and research in Los Angeles and beyond.”
About iCardio.ai
iCardio.ai is a Los Angeles-based company that develops machine learning and deep learning algorithms for the analysis of ultrasound applications, with a specific focus on transthoracic echo. Leveraging a database of over +200M images, iCardio.ai is bringing AI to echocardiography.
See our demo